Association of anemia and cognitive dysfunction in patients with acute myelogenous leukemia and myelodysplastic syndrome

作者：Wood Susan M^*; Meyers Christina A; Faderl Stefan; Kantarjian Hagop M; Pierce Sherry A; Garcia Manero Guillermo

来源：American Journal of Hematology, 2011, 86(11): 950-952.

DOI：10.1002/ajh.22151

Anemia is a symptom associated with cognitive dysfunction and is diagnosed if the hemoglobin level of a blood sample is too low. The clinical impact of chronically low hemoglobin level may be insufficient brain oxygenation, which may result in a decline in cognitive functioning. Previous studies have provided evidence of decrements in cognitive functioning associated with anemia across various disease processes, but few have investigated the association between cognitive dysfunction and hemoglobin level in patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). As this population is inherently anemic, studying these patients allowed for an exploration of cognitive changes at mild, moderate, and severe levels of anemia. This investigation explored cutoff points for hemoglobin at which cognitive decline may occur. Findings showed decrements in cognitive functioning occurring at hemoglobin levels of 10 g/dL or below. Performance on measures of word retrieval, attention, and fine motor function was most affected which suggests fronto-temporal lobe dysfunction. Results provided evidence as to a hemoglobin cutoff point below which cognitive function may be affected in patients with AML and MDS. This cutoff value may provide a clinical marker at which cognitive testing and therapeutic interventions could be utilized to improve patients' cognitive function, level of fatigue and overall quality of life.

• 出版日期2011-11